|
62
|
223
|
5mnbA |
Cationic trypsin in complex with 2-aminopyridine (deuterated sample at 295 k) |
|
56
|
223
|
5mo0A |
Neutron structure of cationic trypsin in complex with benzamidine |
|
57
|
257
|
5mlsH |
Thrombin mutant a190s in complex with (s)-1-(d-phenylalanyl)-n-(3-chlorobenzyl)pyrrolidine-2-carboxamide |
|
61
|
223
|
5mnmA |
Cationic trypsin in complex with benzylamine (at 295 k) |
|
56
|
257
|
5mjtH |
Thrombin mutant a190s in complex with (s) -1 - ((r) -2-amino-3,3-diphenylpropanoyl) -n- (3-chlorobenzyl) pyrrolidine-2-carboxamide |
|
58
|
230
|
5mt0A |
Complement factor d in complex with a reversible indole carboxylic acid based inhibitor |
|
58
|
258
|
5mm6H |
Thrombin mutant a190s in complex with (s)-1-(d-phenylalanyl)-n-(4-carbamimidoylbenzyl)pyrrolidine-2-carboxamide |
|
155
|
505
|
5m6wJ |
Properdin in complex with alternative pathway c3 convertase |
|
58
|
223
|
5mo1A |
Neutron structure of cationic trypsin in complex with benzylamine |
|
63
|
223
|
5mopA |
Joint x-ray/neutron structure of cationic trypsin in its apo form |
|
62
|
223
|
5moqA |
Joint x-ray/neutron structure of cationic trypsin in complex with benzamidine |
|
61
|
223
|
5mnnA |
Cationic trypsin in complex with n-amidinopiperidine (deuterated sample at 100 k) |
|
58
|
223
|
5mnxA |
Neutron structure of cationic trypsin in complex with 2-aminopyridine |
|
57
|
223
|
5mnyA |
Neutron structure of cationic trypsin in complex with aniline |
|
61
|
223
|
5mncA |
Cationic trypsin in complex with aniline (deuterated sample at 100 k) |
|
63
|
223
|
5monA |
Joint x-ray/neutron structure of cationic trypsin in complex with 2-aminopyridine |
|
62
|
223
|
5mnfA |
Cationic trypsin in its apo form (deuterated sample at 295 k) |
|
61
|
223
|
5mnpA |
Cationic trypsin in complex with n-amidinopiperidine (at 295 k) |
|
63
|
223
|
5mnoA |
Cationic trypsin in complex with n-amidinopiperidine (deuterated sample at 295 k) |
|
63
|
223
|
5morA |
Joint x-ray/neutron structure of cationic trypsin in complex with benzylamine |
|
59
|
223
|
5mooA |
Joint x-ray/neutron structure of cationic trypsin in complex with aniline |
|
41
|
226
|
5lpfA |
Kallikrein-related peptidase 10 |
|
59
|
223
|
5lh8A |
Trypsin inhibitors for the treatment of pancreatitis - cpd 8 |
|
57
|
253
|
5lyoA |
Crystal structure of the zymogen matriptase catalytic domain |
|
53
|
247
|
5lhqA |
The egr-cmk active site inhibited catalytic domain of murine urokinase-type plasminogen activator in complex with the allosteric inhibitory nanobody nb7 |
|
44
|
226
|
5lpeA |
Kallikrein-related peptidase 10 complex with zn2+ |
|
61
|
259
|
5l6nH |
Disulfated madanin-thrombin complex |
|
57
|
257
|
5lpdH |
Thrombin in complex with (s)-1-((r)-2-amino-3-cyclohexylpropanoyl)-n-(2-(aminomethyl)-5-chlorobenzyl) pyrrolidine-2-carboxamide |
|
56
|
247
|
5lhrA |
The catalytic domain of murine urokinase-type plasminogen activator in complex with the active site binding inhibitory nanobody nb22 |
|
61
|
223
|
5lh4A |
Trypsin inhibitors for the treatment of pancreatitis - cpd 1 |
|
58
|
223
|
5lgoA |
Trypsin inhibitors for the treatment of pancreatitis - cpd 15 |
|
51
|
198
|
5lprA |
Structural basis for broad specificity in alpha-lytic protease mutants |
|
48
|
247
|
5lhnA |
The catalytic domain of murine urokinase-type plasminogen activator in complex with the allosteric inhibitory nanobody nb7 |
|
60
|
254
|
5l30H |
Factor viia in complex with the inhibitor (2r,15r)-2-[(1-aminoisoquinolin-6-yl)amino]-4,15,17-trimethyl-7-[1-(1h-tetrazol-5-yl)cyclopropyl]-13-oxa-4,11-diazatricyclo[14.2.2.1~6,10~]henicosa-1(18),6(21),7,9,16,19-hexaene-3,12-dione |
|
59
|
254
|
5l2yH |
Factor viia in complex with the inhibitor 1-[(2r,15r)-2-[(1-amino-4-fluoroisoquinolin-6-yl)amino]-4,15,20-trimethyl-3,12-dioxo-13-oxa-4,11-diazatricyclo[14.2.2.1~6,10~]henicosa-1(18),6,8,10(21),16,19-hexaen-7-yl] cyclobutane-1-carboxylic acid |
|
57
|
222
|
5kwmA |
S. erythraea trypsin long construct apoenzyme |
|
59
|
254
|
5l2zH |
Factor viia in complex with the inhibitor 1-[(2r,15r)-2-[(1-amino-4-fluoroisoquinolin-6-yl)amino]-4,15,17-trimethyl-3,12-dioxo-13-oxa-4,11-diazatricyclo[14.2.2.1~6,10~]henicosa-1(18),6(21),7,9,16,19-hexaen-7-yl]cyclohexane-1-carboxylic acid |
|
53
|
223
|
5k7rA |
Microed structure of trypsin at 1.7 a resolution |
|
56
|
258
|
5jfdH |
Thrombin in complex with (s)-n-(2-(aminomethyl)-5-chlorobenzyl)-1-((benzylsulfonyl)-d-arginyl)pyrrolidine-2-carboxamide |
|
58
|
257
|
5jzyH |
Thrombin in complex with (s)-1-((r)-2-amino-3-cyclohexylpropanoyl)-n-(4-carbamimidoylbenzyl)pyrrolidine-2-carboxamide |
|
61
|
234
|
5k0hA |
Human factor xa in complex with synthetic inhibitor benzylsulfonyl-dser(benzyl)-gly-4-amidinobenzylamide |
|
56
|
259
|
5jduB |
Crystal structure for human thrombin mutant d189a |
|
44
|
242
|
5jpmH |
Structure of the complex of human complement c4 with masp-2 rebuilt using imdff |
|
53
|
223
|
5jyiA |
Trypsin bound with succinic acid at 1.9a |
|
51
|
235
|
5jb9S |
Crystal structure of factor ixa k98t variant in complex with ppack |
|
54
|
235
|
5jbaS |
Crystal structure of factor ixa variant v16i k98t y177t i212v in complex with ppack |
|
50
|
235
|
5jbcS |
Crystal structure of factor ixa variant v16i k98t y177t i213v in complex with ppack |
|
51
|
235
|
5jb8S |
Crystal structure of factor ixa variant k98t in complex with egr-chloromethylketone |
|
59
|
224
|
5jbtA |
Mesotrypsin in complex with cleaved amyloid precursor like protein 2 inhibitor (aplp2) |
|
49
|
245
|
5j4qA |
Alpha-chymotrypsin from bovine pancreas in complex with bowman-birk inhibitor from soybean |
